Windsor Wealth Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,024
Closed -$483K 169
2022
Q1
$483K Sell
6,024
-140
-2% -$11.1K 0.09% 151
2021
Q4
$523K Buy
6,164
+840
+16% +$65.6K 0.1% 150
2021
Q3
$402K Buy
5,324
+1,116
+27% +$88.6K 0.08% 163
2021
Q2
$342K Sell
4,208
-700
-14% -$57.2K 0.07% 169
2021
Q1
$387K Sell
4,908
-16
-0.3% -$1.25K 0.09% 157
2020
Q4
$421K Buy
4,924
+63
+1% +$5.21K 0.11% 144
2020
Q3
$383K Buy
4,861
+857
+21% +$65.3K 0.11% 144
2020
Q2
$293K Buy
4,004
+872
+28% +$61.9K 0.09% 155
2020
Q1
$208K Sell
3,132
-48
-2% -$3.38K 0.08% 170
2019
Q4
$219K Sell
3,180
-76
-2% -$5.18K 0.08% 178
2019
Q3
$230K Sell
3,256
-276
-8% -$20K 0.1% 164
2019
Q2
$255K Buy
3,532
+174
+5% +$12.4K 0.11% 156
2019
Q1
$230K Buy
+3,358
New +$217K 0.13% 138
2018
Q3
Sell
-4,859
Closed -$315K 135
2018
Q2
$315K Sell
4,859
-587
-11% -$38.4K 0.25% 99
2018
Q1
$390K Sell
5,446
-30
-0.5% -$2.16K 0.33% 85
2017
Q4
$413K Buy
+5,476
New +$400K 0.36% 72

Other funds holding CL

Windsor Wealth Management's CL Position: Q2 2022 in Review

Windsor Wealth Management sold out of Colgate-Palmolive (CL) in Q2 2022, closing a stake of 6,024 shares — an estimated $483K sold.

Windsor Wealth Management first reported a position in CL in Q4 2017 and held it in 16 quarters. The position peaked at $523K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CL as of Q2 2022.

  • Windsor Wealth Management reported no remaining Colgate-Palmolive position as of Q2 2022 after selling out during the quarter.
  • Windsor Wealth Management sold 6,024 Colgate-Palmolive shares in Q2 2022, an estimated $483K.
  • Windsor Wealth Management first reported a position in Colgate-Palmolive in Q4 2017 and held it in 16 quarters.
  • Windsor Wealth Management's Colgate-Palmolive position peaked at $523K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2022.

Based on Windsor Wealth Management's 13F filing for Q2 2022, filed 8 Aug 2022.